A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Public ClinicalTrials.gov record NCT06857942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice
Study identification
- NCT ID
- NCT06857942
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Tirzepatide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2025
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
- Last update posted
- Apr 16, 2026
2025 – 2028
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists | Phoenix | Arizona | 85006 | Recruiting |
| First OC Dermatology Research Inc | Fountain Valley | California | 92708 | Recruiting |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | Recruiting |
| Metropolis Dermatology | Los Angeles | California | 90017 | Recruiting |
| Northridge Clinical Trials | Northridge | California | 91325 | Recruiting |
| Alliance for Multispecialty Research, LLC | Fort Myers | Florida | 33912 | Recruiting |
| NeoClinical Research | Hialeah | Florida | 33016 | Recruiting |
| Skin Care Research | Hollywood | Florida | 33021 | Recruiting |
| Encore Medical Research | Hollywood | Florida | 33024 | Recruiting |
| MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research | Tampa | Florida | 33607 | Recruiting |
| TruDerm & TruSpa | Wellington | Florida | 33449 | Recruiting |
| Southeast Research Specialists | Douglasville | Georgia | 30135 | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | Recruiting |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | Recruiting |
| Equity Medical - Bowling Green | Bowling Green | Kentucky | 42104 | Recruiting |
| Dermatology and Skin Cancer Specialists, LLC | Rockville | Maryland | 20850 | Recruiting |
| Metro Boston Clinical Partners | Brighton | Massachusetts | 02135 | Recruiting |
| David Fivenson, MD, PLC | Ann Arbor | Michigan | 48103 | Recruiting |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | Recruiting |
| The Derm Institute of West Michigan | Caledonia | Michigan | 49316 | Recruiting |
| Skin Cancer and Dermatology Institute - Reno | Reno | Nevada | 89509 | Recruiting |
| Stracskin | Portsmouth | New Hampshire | 03801 | Recruiting |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | Recruiting |
| Care Access - Hoboken | Hoboken | New Jersey | 07030 | Recruiting |
| Equity Medical | New York | New York | 10023 | Recruiting |
| Revival Research Institute, LLC | Cary | North Carolina | 27511 | Recruiting |
| Onsite Clinical Solutions - Huntersville | Huntersville | North Carolina | 28078 | Recruiting |
| Optima Research - Boardman | Boardman | Ohio | 44512 | Recruiting |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | Recruiting |
| Dermatology Associates of Plymouth Meeting | Plymouth Meeting | Pennsylvania | 19462 | Recruiting |
| Columbia Dermatology & Aesthetics | Columbia | South Carolina | 29212 | Recruiting |
| Alliance for Multispecialty Research, LLC | Myrtle Beach | South Carolina | 29588 | Recruiting |
| DelRicht Research - Thompson's Station | Smyrna | Tennessee | 37167 | Recruiting |
| Bellaire Dermatology Associates | Bellaire | Texas | 77401 | Recruiting |
| Modern Research Associates, PLLC | Dallas | Texas | 75231 | Recruiting |
| Center for Clinical Studies | Houston | Texas | 77004 | Recruiting |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | Recruiting |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | Recruiting |
| Center for Clinical Studies | Webster | Texas | 77598 | Recruiting |
| Tanner Clinic | Layton | Utah | 84041 | Recruiting |
| Bellevue Dermatology Clinic | Bellevue | Washington | 98104 | Recruiting |
| Dermatology of Seattle | Burien | Washington | 98168 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06857942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06857942 live on ClinicalTrials.gov.